1840 PROSTATE VOLUME ADJUSTMENT WITH RECTAL EXAMINATION (DRE) WITHIN THE ERSPC RISK CALCULATOR - The Journal of Urologydoi:10.1016/j.juro.2010.02.1779Roobol, Monique J.Kranse, RiesSchr?der, Fritz H.Elsevier Inc.Journal of Urology
presentation, [68Ga]Ga-PSMA-11 PET/CT demonstrated higher diagnostic efficacy for PI-RADS 3 score patients and had an advantage over the european randomized study of screening for prostate cancer risk calculator 3 (ERSPC-RC3) and prostate cancer prevention trial risk calculator (PCPT-RC) models...
Nguyen CT, Yu C, Moussa A, Kattan MW, Jones JS. Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy. J Urol. 2010;183(2):529-533.PubMedGoogle ScholarCrossref 99. Hernandez DJ, Han ...
Fig. 1:CHD1copy number by FISH in tissue microarrays. aProstate cancer cells with wild type (diploid)CHD1(upper left) vs. prostate cancer cells harboring mono-allelic deletion forCHD1(upper right) are visualized by FISH assay. Orange signal:CHD1probe; green signal: human chromosome 5 short ...
van 0,16 in vergelijking met een model waarin iedereen een PSMA PET/CT-scan zou krijgen (fig.1). Om het gebruiksgemak voor clinici te verhogen, is het model in een dashboard verwerkt (https://psma.prostatecancer-riskcalculator.com/). Figuur2illustreert het gebruik van het dashboard...
Statistical models such as the Prostate Cancer Prevention Trial risk calculator have been developed to estimate the cancer risk in an individual and help d... CT Nguyen,C Yu,A Moussa,... - 《J Urol》 被引量: 77发表: 2010年 External validation of the Prostate Cancer Prevention Trial and ...
https://doi.org/10.1016/j.ctarc.2023.100739 Kelly, B. D., Ptasznik, G., Roberts, M. J., Doan, P., Stricker, P., Thompson, J., … Moon, D. (2023). A novel risk calculator incorporating clinical parameters, multiparametric magnetic resonance imaging, and prostate-specific membrane ...
al.[15], Roobol[16]suggested that, as long as thePSA testis the mainstay in the decision to perform a prostate biopsy, information on prostate volume must be taken into account, preferably on the basis of an objective individual risk assessment using an risk calculator (RC) or a nomogram....
Novel non-MRI imaging techniques for primary diagnosis of prostate cancer: micro-ultrasound, contrast-enhanced ultrasound, elastography, multiparametric ultrasound, and PSMA PET/CT Article 05 August 2023 Lesion size may affect diagnostic capabilities of MRI-guided ultrasound fusion biopsy and cognitive...
The DLPT-nomogram (NAFNet-classifier integrated with PSA and cT stage) was then established and had a higher post-surgical ISUP high-risk predicting performance than the clinical score (PBCG) (P = 0.003). Additionally, NAFNet-classifier alone also outperformed the PBCG score in both ROC...